John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Central Garden & Pet Co Class A
CENTA
$2.4B
| $1.97M | 0.01% |
180,834
+50,335
| +39% | +$648K |
|
1102
InterContinental Hotels
IHG
$24B
| $1.97M | 0.01% |
38,493
-80,167
| -68% | -$4.03M |
|
1103
AB InBev
BUD
$156B
| $1.97M | 0.01% |
15,730
-85,718
| -84% | -$10.4M |
|
|
PNRA
1104
PUT
DELISTED
Panera Bread Co
PNRA
| $1.95M | 0.01% |
10,000
+3,000
| +43% | +$557K |
|
1105
Oxford Square Capital
OXSQ
$150M
| $1.94M | 0.01% |
318,839
+137,135
| +75% | +$897K |
|
|
TRIB
1106
Trinity Biotech
TRIB
$8.4M
| $1.93M | 0.01% |
1,096
+471
| +75% | +$834K |
|
|
RPXC
1107
DELISTED
RPX Corporation
RPXC
| $1.93M | 0.01% |
+175,770
| New | +$2.38M |
|
|
SRCI
1108
DELISTED
SRC Energy Inc
SRCI
| $1.93M | 0.01% |
+226,365
| New | +$2.44M |
|
1109
MYR Group
MYRG
$4.75B
| $1.93M | 0.01% |
93,500
+80,403
| +614% | +$1.74M |
|
|
CKP
1110
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $1.92M | 0.01% |
306,006
+189,976
| +164% | +$1.28M |
|
1111
PUT
Zoetis
ZTS
$31.9B
| $1.92M | 0.01% |
+40,000
| New | +$1.81M |
|
1112
CALL
Ford
F
$55.5B
| $1.92M | 0.01% |
136,000
+125,500
| +1,195% | +$1.82M |
|
|
RFP
1113
DELISTED
Resolute Forest Products Inc.
RFP
| $1.91M | 0.01% |
252,661
+240,346
| +1,952% | +$1.96M |
|
1114
BioMarin Pharmaceuticals
BMRN
$12.6B
| $1.9M | 0.01% |
18,100
-61,810
| -77% | -$6.45M |
|
1115
Canadian Natural Resources
CNQ
$104B
| $1.89M | 0.01% |
179,345
-151,703
| -46% | -$1.69M |
|
1116
Intrepid Potash
IPI
$510M
| $1.89M | 0.01% |
64,032
+37,980
| +146% | +$1.6M |
|
|
PPL
1117
PPL Corp
PPL
$26.4B
| $1.88M | 0.01% |
55,185
-166,730
| -75% | -$5.62M |
|
1118
CALL
Delta Air Lines
DAL
$54.2B
| $1.88M | 0.01% |
37,000
-40,000
| -52% | -$1.98M |
|
1119
Super Micro Computer
SMCI
$22.8B
| $1.88M | 0.01% |
765,540
+368,100
| +93% | +$961K |
|
1120
Kinross Gold
KGC
$39.1B
| $1.87M | 0.01% |
1,026,678
+1,012,978
| +7,394% | +$2M |
|
|
CBPO
1121
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $1.87M | 0.01% |
13,100
-96,974
| -88% | -$11.2M |
|
1122
Enviri
NVRI
$595M
| $1.86M | 0.01% |
236,624
+63,782
| +37% | +$624K |
|
1123
Kadant
KAI
$3.69B
| $1.86M | 0.01% |
45,848
-559
| -1% | -$23K |
|
1124
Ralph Lauren
RL
$22.1B
| $1.86M | 0.01% |
16,688
-210,991
| -93% | -$25M |
|
|
CCEC
1125
Capital Clean Energy Carriers
CCEC
$1.38B
| $1.85M | 0.01% |
48,018
+39,795
| +484% | +$1.77M |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.